Oestrogen receptor expression was determined from the pathology reports that accompanied each tumour specimen, and the expression of PLD1, phospho-Akt, phospho-mTOR, and CKs 5/17 was evaluated by IHC analysis (Table 2). This evidence concerns the gene MTOR and neoplasm.